Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Quantum BioPharma Ltd’s current trading price is 8.07% away from its 52-week high, while its distance from the 52-week low is 852.96%. The stock’s price range during this period has varied between $2.70 and $23.81. The company, active in the Healthcare sector, saw a trading volume of around 0.78 million for the day, considerably higher average daily volume of 0.6 million observed over the last three months.
The stock market performance of Quantum BioPharma Ltd has been very steady. Over the last year, the company’s stock hit its highest at $23.81 on 06/17/25, while the lowest price during the same time frame was $2.70, recorded on 12/20/24.
How Financial Performance Impacts Market Capitalization
Quantum BioPharma Ltd (QNTM) has experienced a quarterly rise of 295.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 69.73M and boasts a workforce of 7 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
How QNTM’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for QNTM stands at 0.22. Similarly, the long-term debt-to-equity ratio is also 0.00.
QNTM Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price gain of 599.18% this year. Over the last six months, there has been a weaker performance of 511.16%. The price of QNTM fallen by 151.02% during the last 30 days period. For the last 5-days stocks have improved 76.84%.